User contributions
Jump to navigation
Jump to search
- 17:12, 24 July 2022 diff hist 0 File:Durvalumab.pdf PeterYang uploaded a new version of File:Durvalumab.pdf current
- 17:11, 24 July 2022 diff hist 0 File:Pembrolizumab.pdf PeterYang uploaded a new version of File:Pembrolizumab.pdf current
- 17:10, 24 July 2022 diff hist 0 File:Nivolumab.pdf PeterYang uploaded a new version of File:Nivolumab.pdf current
- 17:09, 24 July 2022 diff hist 0 File:Avelumab.pdf PeterYang uploaded a new version of File:Avelumab.pdf current
- 17:08, 24 July 2022 diff hist 0 File:Cabazitaxel.pdf PeterYang uploaded a new version of File:Cabazitaxel.pdf current
- 17:07, 24 July 2022 diff hist 0 File:Enzalutamide.pdf PeterYang uploaded a new version of File:Enzalutamide.pdf current
- 17:03, 24 July 2022 diff hist 0 File:Apalutamide.pdf PeterYang uploaded a new version of File:Apalutamide.pdf current
- 17:02, 24 July 2022 diff hist 0 File:Darolutamide.pdf PeterYang uploaded a new version of File:Darolutamide.pdf
- 16:55, 24 July 2022 diff hist 0 File:Leuprolideeligard.pdf PeterYang uploaded a new version of File:Leuprolideeligard.pdf current
- 16:55, 24 July 2022 diff hist -30 Leuprolide (Lupron) updated links
- 16:52, 24 July 2022 diff hist 0 File:Leuprolidelupron.pdf PeterYang uploaded a new version of File:Leuprolidelupron.pdf current
- 19:56, 23 July 2022 diff hist 0 File:Ibrutinib.pdf PeterYang uploaded a new version of File:Ibrutinib.pdf current
- 19:53, 23 July 2022 diff hist 0 File:Obinutuzumab.pdf PeterYang uploaded a new version of File:Obinutuzumab.pdf current
- 19:51, 23 July 2022 diff hist +623 Obinutuzumab (Gazyva) →Patient drug information
- 19:47, 23 July 2022 diff hist +552 Acalabrutinib (Calquence) →Patient drug information
- 23:04, 9 July 2022 diff hist -15 m Editing test page 2 Tag: visualeditor
- 13:38, 14 May 2022 diff hist +13 m Editing test page 2 Tag: visualeditor
- 18:15, 7 April 2022 diff hist +93 Renal cell carcinoma →References
- 23:25, 24 March 2022 diff hist +1,586 Prostate cancer →Radioactive agents for bony metastatic disease: added lutetium PSMA
- 23:02, 24 March 2022 diff hist +2,861 N Gallium Ga 68 gozetotide (Locametz) FDA approval